On June 13th, a business project cooperation negotiation meeting between Gaible and the UK medical AI expert team was held at Gaible's Shanghai headquarters.

Ke Xin, Chairman of Gaible, Shen Yonglin, Director, Wang Dongsheng, Vice President, and Mr. Zhang, a medical guidance expert, attended the meeting. The online attendees included Ms. Wang, a British expert group, Mr. Chen, CEO of British Medical AI China, and Dr. Bi, an AI technology expert.

At the meeting, Liu Qianwen, the head of the marketing department of Gaible, introduced the company's overview, main products, core competitiveness, and social responsibility. It focuses on the company's research and development capabilities, product performance advantages, and future development and planning.

Mr. Chen, CEO of British Medical AI China, gave a wonderful product speech to everyone, mainly introducing the functions, application fields, technical advantages, brand advantages, business models, etc. of medical AI products.

This product is an AI intelligent product jointly developed by the Department of Medicine, Department of Neurology, and Department of Computer Science at the University of Oxford in the UK. It focuses on medical patients and aims to help them return to normal life and improve their quality of life.

Ke Xin, Chairman of Gaible, stated that artificial intelligence is the future development trend, not only changing lifestyle, but also providing new development opportunities and business models for various industries. Gaible acknowledges the market prospects of this product. Gaible has been established for 15 years now, possessing strong manufacturing capabilities, advanced management concepts, a sound market operation system, and strong resource integration capabilities. We hope that both parties can reach cooperation and utilize their own advantages to achieve resource complementarity. In the future, when the opportunity is ripe, the production of this product can be transferred to China, which has a complete supply chain system and a huge consumer market. Localizing and localizing the product is more conducive to expanding financing and market scale.

Shen Yonglin, Director of Gaible, Wang Dongsheng, Vice President, and Mr. Zhang, a medical guidance expert, conducted in-depth exchanges and discussions on the design principles, working principles, and cooperation models of the product.

This negotiation meeting has laid the foundation for the commercial cooperation between Gaible and the British company. Both parties are working together to open up the Chinese market, bring high-quality products to China, and effectively solve the problem of inconvenience for medical patients.